NCT01272037 2026-03-18
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
University Hospital, Strasbourg, France
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology